Camarda Financial Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Camarda Financial Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-446	Closed	-$63K	–	184
2019 Q2	$63K	Buy	446 +306	+219%	+$42.2K	0.12%	64
2019 Q1	$21K	Buy	+140	New	+$20.1K	0.04%	133
2016 Q1	–	Sell	-178	Closed	-$20K	–	270
2015 Q4	$20K	Buy	+178	New	+$19.2K	0.01%	182

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Camarda Financial Advisors's FBT Position: Q3 2019 in Review

Camarda Financial Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2019, closing a stake of 446 shares — an estimated $63K sold.

Camarda Financial Advisors first reported a position in FBT in Q4 2015 and held it in 3 quarters. The position peaked at $63K in Q2 2019. 188 funds tracked by Wall St. Rank hold FBT as of Q3 2019.

Camarda Financial Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2019 after selling out during the quarter.
Camarda Financial Advisors sold 446 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2019, an estimated $63K.
Camarda Financial Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2015 and held it in 3 quarters.
Camarda Financial Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $63K in Q2 2019.
188 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2019.

Based on Camarda Financial Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.